C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2011
11/17/2011	US20110281789 Ulbp antibodies
11/17/2011	US20110281769 siRNA targeting beta secretase (BACE)
11/17/2011	US20110281767 Compositions and methods for molecular biology
11/17/2011	US20110281761 Multi-chain eukaryotic display vectors and uses thereof
11/17/2011	US20110281751 Cell surface display of polypeptide isoforms by stop codon readthrough
11/17/2011	US20110281362 Electrotransformation of Gram-Positive, Anaerobic, Thermophilic Bacteria
11/17/2011	US20110281361 Linear donor constructs for targeted integration
11/17/2011	US20110281360 Multi-chain eukaryotic display vectors and uses thereof
11/17/2011	US20110281359 Spnk strains
11/17/2011	US20110281349 Insect Desiccation Resistance Genes and Uses Thereof
11/17/2011	US20110281348 Agonist anti-trkc antibodies and methods using same
11/17/2011	US20110281347 Multivalent vaccines comprising recombinant viral vectors
11/17/2011	US20110281330 Minicells expressing antibodies or derivatives thereof and comprising biologically active compounds
11/17/2011	US20110281325 Lipolytic enzyme lip1
11/17/2011	US20110281323 Novel Fungal Laccases and Uses Thereof
11/17/2011	US20110281313 Improved production of acid and solvent in microorganisms
11/17/2011	US20110281309 Novel amino acid dehydrogenase, and process for producing l-amino acid, 2-oxo acid or d-amino acid
11/17/2011	US20110281305 Modified type a dna polymerases
11/17/2011	US20110281301 The secretory capacity in host cells
11/17/2011	US20110281300 Preparation method of recombinant protein by use of a fusion expression partner
11/17/2011	US20110281299 Recombinant Pokeweed Antiviral Proteins, Compositions and Methods Related Thereto
11/17/2011	US20110281292 Compositions and methods for identifying antigens which elicit an immune response
11/17/2011	US20110281286 Expression vector for establishing highly productive cell and the highly productive cell
11/17/2011	US20110281276 Nucleic acid-free thermostable enzymes and methods of production thereof
11/17/2011	US20110281273 Method of making dna tag
11/17/2011	US20110281261 Vectors
11/17/2011	US20110281257 Method for producing beta-santalene
11/17/2011	US20110280935 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies
11/17/2011	US20110280929 Sirna of nf-kb p105 for inhibiting cell proliferation and migration and a composition comprising same
11/17/2011	US20110280910 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis
11/17/2011	US20110280905 Live attenuated chimeric porcine circovirus vaccine
11/17/2011	US20110280901 Diagnosis and treatment of Trypanosoma cruzi infection and chagas disease
11/17/2011	US20110280894 Her2/neu specific t cell receptors
11/17/2011	US20110280892 Toxin conjugated eph receptor antibodies
11/17/2011	US20110280889 High affinity t cell receptor and use thereof
11/17/2011	US20110280888 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
11/17/2011	US20110280885 Cancer immunotherapy
11/17/2011	US20110280884 Anti-cd98 antibody
11/17/2011	US20110280883 Fully human anti-epidermal growth factor receptor antibodies
11/17/2011	US20110280882 Leukolectins and uses thereof
11/17/2011	US20110280880 Prevention, treatment and diagnosis of p.gingivalis infection
11/17/2011	US20110280879 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies
11/17/2011	US20110280878 Substance specific to human pd-1
11/17/2011	US20110280876 Mutated netrin - 4, fragments thereof and their use as medicines
11/17/2011	US20110280873 MCP1-Ig FUSION VARIANTS
11/17/2011	US20110280870 Hepatocyte growth factor receptor antagonists and uses thereof
11/17/2011	US20110280861 Method for mir-125a in promoting hematopoietic stem cell self renewal and expansion
11/17/2011	US20110280859 Preventing and treating sepsis
11/17/2011	US20110280858 Treatment of wounds
11/17/2011	US20110280856 Treatment of alpha-galactosidase a deficiency
11/17/2011	US20110280842 Methods of reprogramming cells
11/17/2011	US20110280836 Compositions for bacterial mediated gene silencing and methods of using the same
11/17/2011	US20110280832 Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
11/17/2011	US20110280830 Albumin Fusion Proteins
11/17/2011	US20110280800 Il-1 binding proteins
11/17/2011	DE10393660B4 Verfahren zur Identifizierung von Protein-CAMs (konstitutiv aktive Mutanten) A method of identifying protein CAMs (constitutively active mutants)
11/17/2011	CA2833415A1 Gene therapy for diabetes with chitosan-delivered plasmid encoding glucagon-like peptide 1
11/17/2011	CA2816925A1 Nucleic acid-containing lipid particles and related methods
11/17/2011	CA2805086A1 Antisense modulation of interleukins 17 and 23 signaling
11/17/2011	CA2800311A1 Anti-fgfr2 antibodies
11/17/2011	CA2799470A1 Humanized ttc and methods of use thereof
11/17/2011	CA2799403A1 Compositions and methods for treating leukemia
11/17/2011	CA2799373A1 Compositions and methods for modulating metabolism
11/17/2011	CA2799091A1 Novel cationic lipids and methods of use thereof
11/17/2011	CA2799046A1 Il-1 binding proteins
11/17/2011	CA2798905A1 Growth promoting fusion proteins
11/17/2011	CA2798886A1 Spnk strains
11/17/2011	CA2798401A1 Treatment of par4 related diseases by inhibition of natural antisense transcript to par4
11/17/2011	CA2797720A1 Humanized and chimeric monoclonal antibodies to cd47
11/17/2011	CA2795226A1 Use of brown midrib-3 gene specific markers in maize for trait introgression
11/17/2011	CA2792314A1 Modulation of scleraxis using a dominant negative scleraxis mutant with a basic dna-binding domain deletion
11/17/2011	CA2789583A1 Yeast microorganisms with reduced by-product accumulation for improved production of fuels, chemicals, and amino acids
11/17/2011	CA2788821A1 Isothermal amplification of nucleic acid using primers comprising a randomized sequence and specific primers and uses thereof
11/17/2011	CA2784666A1 Modified clostridial toxins comprising an integrated protease cleavage site-binding domain
11/16/2011	EP2386856A2 Methods and means for treatment of osteoarthritis
11/16/2011	EP2386651A1 Method for screening for salty taste control substance
11/16/2011	EP2386650A1 Method for producing L-amino acids using the gap promoter
11/16/2011	EP2386647A1 Method for transfecting a eukaryotic cell
11/16/2011	EP2386646A1 Gene delivery system and methods of use
11/16/2011	EP2386645A2 Vector for treatment vaccine for stable and constitutive high-expression cervical cancer and recombinant lactobacillus transformed by the same
11/16/2011	EP2386644A2 Expression system
11/16/2011	EP2386643A2 Expression system
11/16/2011	EP2386642A2 Expression system
11/16/2011	EP2386641A1 Method for extracellular production of recombinant biomolecules in a microorganism
11/16/2011	EP2386639A2 Modified pore-forming protein toxins and use thereof
11/16/2011	EP2386638A2 Method for isolation of soluble polypeptides
11/16/2011	EP2386637A2 MicroRNA molecules
11/16/2011	EP2386636A2 ENA nucleic acid drugs modifying splicing in mRNA precursor
11/16/2011	EP2386635A2 Mutant G-protein coupled receptors (GPCR) and methods for selecting them
11/16/2011	EP2386634A1 Sterol side chain-cleaving enzyme protein and use thereof
11/16/2011	EP2386630A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
11/16/2011	EP2386629A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
11/16/2011	EP2386625A2 Methods for production of xylitol in microorganisms
11/16/2011	EP2386575A2 Dual specificity antibodies and methods of making and using
11/16/2011	EP2386574A2 Polypeptide variants with altered effector function
11/16/2011	EP2386573A1 Transgenic animal with enhanced immune response and method for the preparation thereof
11/16/2011	EP2386571A2 Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
11/16/2011	EP2386570A1 Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies and compositions thereof
11/16/2011	EP2386569A1 Alpha-amylase mutants
11/16/2011	EP2386568A1 Alpha-amylase mutants

1 ... 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 ... 4023